Objective: To determine the clinical symptoms in adult ficiency for arylsulfatase A.
ETA c h r o m a t ic leuko dystrophy (MLD) is an autosomal recessive ly sosomal disorder char acterized by demyelination of the white matter in the central nervous system and the peripheral nerves. The gene is located on chrom osom e 22ql3. 1 Accumulation of sulfatides can be found in the brain, peripheral nerves, and nonneural organs. The disease is caused by a deficiency of the enzyme arylsulfa tase A (ASA), which hydrolyzes various sulfatides, including galactosyl sulfatide and lactosyl sulfatide, the major sulfatecontaining lipids of the nervous system. The diagnosis of MLD is based on de creased ASA activity in leukocytes or fi broblasts and accumulation of sulfatides in urinary sediment or various tissues, eg, sural nerve.
Clinically different forms of MLD can be distinguished according to the severity and the age at onset of the disease. The lateinfantile form (age at onset, 1 to 2 years) is characterized by gait and behavioral distur bances; the disease course is rapid and the outcome is fatal. 2 The juvenile form of MLD (age at onset, 3 to 15 years) has a more pro tracted course. 3 The adult form of MLD (age at onset older than 16 years) has a slowly progressive course. Compared with the lateinfantile and juvenile forms of MLD, the adult variant appears to be quite rare. Un til now, to our knowledge, only 24 pa tients w ith adult MLD have been de scribed in the literature. In these patients, a low ASA level was accompanied by accu mulation of sulfatides. 4'6 The determination of ASA deficiency alone is insufficient for a diagnosis of MLD, because a pseudodeficiency (PD) state has also been observed. 7 In the PD state, low ASA activity is not accompanied by accu mulation of sulfatides in the organs, be cause the residual activity is supposedly suffic ie n t to e n su re n o rm a l su lfatid e metabolism. This PD state is a common ge netic polymorphism, with an estimated gene frequency of 7.3% in central Europe,H and is caused by a mutation affecting the polyadenylation of the ASA mRNA. 7 Until now, eight different MLD alle les have been described.0 The three dif- 
PATIENTS W IT H MLD
The diagnosis of MLD was confirmed in 13 patients by morphologic demonstration of storage material in the sural nerve or brain an cl/or increased amounts of sulfa tides in urinary sediment (Table 1 ). Two pa tients (patients 2 and 3) have been described previ ously. 10 In patient 3, ASA activity was not determined, but we can be sure of the diagnosis because he was the brother of patient 2 ; they presented with similar clinical features, and a postmortem ncuropathologic examination revealed accumulation of sulfatides in the brains of both patients. A survey of technical mea surements performed in the patients with adult MLD is presented in Table 1 . Electromyography (EMG) was performed in 1 1 patients, and analysis of cerebrospi nal fluid was performed in 1 0 patients, Neither com puted tomography (CT) nor magnetic resonance im aging (MRI) was available during the lifetime of pa tients 1 through 4. Peripheral nerve biopsy specimens from four patients (patients 2,4, 5, and 6 ) were stud ied in our department, and the morphologic changes were compared with the features in late-infantile and juvenile cases. Pathologic examination of the sural nerve of patients 9,12, and 13 was performed in other hospitals.
PATIENTS W IT H PD
Twelve patients with low ASA activity were found to be homozygotic for the PD mutation. Lysosomal en zyme determination in these patients was requested based on progressive neurologic or psychiatric signs and symptoms of unknown etiology. Examination of the sural nerve was performed in two patients. In the other 1 0 patients, biopsy was not performed be cause they showed no neurophysio logic or radiologic symptoms o fie ukodys trophy, and DN A analysis for PD became available. In all patients, DNA analysis was perfonned. In three pa tien is, ti n na Iysis was per ror med, Ten patients underwent EMG, nine under went CT, and three underwent MRI. The cerebrospi nal fluid from five patients was analyzed. Arylsulfatase A activity was measured in leukocyte supernatants after sonification with use of p-nitrocatecholsulfate as substrate, as described by Galjnard,11 Urinary sulfatides were extracted from sedimen is, sepa rated by thin-layer chromatography from other glycolipids, and estimated semiquantitatively after naphlhol staining, Leukocyte genomic DNA was initially typed for the PD allele by the method of Gieselmann12 and later by the method of Nelson et al.n ity for type 0 alleles is associated with the late-infantile form. Homozygosity for the type R alleles is present in adult forms, while type O/type R compound heterozy gotes have intermediate (juvenile) phenotypes.Ĥ erein, we describe 25 adult patients with low ASA activity. In 13 patients, the diagnosis of adult MLD was confirmed by demonstration of sulfatide accumulation. In 1 2 patients, no accumulation could be demonstrated. In the latter group, a diagnosis of PD was established by means of DNA analysis. The data from both groups are compared with data from the literature.
RLSUIIS
ferent forms of the disease can be explained by the ex istence of two types of alleles; type 0 alleles without and type R alleles with some residual activity, Homozygos
The range of ASA activity in the leukocytes of the 13 pa tients with adult MLD was 1 to 12 nmol/h per milligram of protein (reference range, 35 to 110 nmol/h per milli gram of protein) (Figure 1 ). The mean age at onset in the adult MLD group was 23 years (range, 16 to 31 years). The presenting clinical symptoms were behaviohil abnormali ties (n=4 ), ataxia (n=4 ), polyneuropathy (ii=2 ), dementia (n=:2 ), and paraparesis (n=l) ( T a b l e 2 ) , The behavioral abnormalities consisted of aggressiveness, irritability, im paired social awareness, and inappropriate behavior, The interval between age at onset and age of occurrence of the second symptom was, on average, 3.7 years (range, 1 to 20 years). The third symptom occurred, on average, 2.0 years (range, 0 to 7 years) after the second symptom. The development of the main symptoms is graphically pre sented in Figure % , In the final stage of the disease, most of the patients were suffering from mental deterioration (n=1 0 ) and showed severe ataxia (n=8 ) and behavioral ab normalities (n=6 ). Three patients developed epilepsy. None of the patients became psychotic, except for patient 3, who suffered from auditory hallucinations, Plantar response was flexor in six patients and extensor in seven patients. In three patients, paraparesis was evident All of the patients with MLD who underwent EMG showed a slowing of the nerve conduction velocities (NCVs) ( Table 1 ). The mean NCV of the peroneal nerve was 24.4 m/s (range, 15 to 39 m/s; reference range, 4-4 to 57 m/s).
Neuropat ho logic examination of the sural nerve in three patients (patients 2,4, and 5) revealed, with acidic cresyl violet staining, the presence of brown metachro matic deposits in Schwann cells and in large perivascu lar macrophages, A process oTsegmental dcmyelination and remyelination with slight onion bulb formation was present, but this was less active than in the late-infantile and juvenile forms, and myelinated fiber density was only slightly reduced, in contrast to the more pronounced re duction in the earlier-onset cases, Myelin sheath thick ness was clearly reduced, especially that of the large fi bers. In patient 6 , the m yelinated fiber density, the percentage of large fibers, and the myelin thickness were normal. There were few signs of segmental dcmycUnation and remyelination, but accumulation of metachro matic material was in the same range as in most adult and juvenile cases. Ultras truetural examination in all four patients revealed various types of inclusions, mainly la mellar zebralike bodies and tuffstone bodies. The speci mens from the three patients whose biopsies were per formed in other hospitals were not available for review, but accumulation of m etachrom atic material was re ported in all of them.
Computed tomography was performed in nine pa tients and revealed areas of hypo density in the white mat ter, especially in the frontal lobes. Magnetic resonance imaging was performed in three patients and showed dif fuse demyelination of the periventricular white matter (Figure 3) .
Analysis of cerebrospinal fluid from 10 patients re vealed normal (n=7) or slightly elevated (n=3) protein levels (range, 0.26 to 0.73 g/L) (reference range, 0.18 to 0.58 g/L).
At the time of this writing, nine of these patients have died. On average, death occurred 9.8 years (range, 3 to 24 years) after onset of the disease. Four patients are still alive an average of 16 years (range, 1 1 to 27 years) after disease onset.
In the 12 other patients with very low ASA activity, DNA analysis revealed homozygosity for the PD allele. The ASA activity in this group ranged from 6 to 25 nmol/h per milligram of protein. The levels of ASA activity for both groups are presented in Figure 1 . The complaints of these patients were memory disturbances (n=6 ), ataxia (n=2 ), fatigue (n~2), tremor (n=l), and loss of vision (n=l). These patients were not related to patients known to have MLD. One patient was found to have multiple sclerosis, one was found to have Parkinson's disease, one was found to have Huntington's disease, and one was found to have an is chemic optic neuropathy. Neurologic and neuropsycho logical examinations of the six patients with memory com plaints revealed no abnormalities, In addition, EMG, CT, and MRI yielded normal findings, while no evident ab normalities were found in the cerebrospinal fluid, with the exception of an elevated IgG index and oligoclonal bands in the patient with multiple sclerosis. Analysis of the urine revealed no evidence of accumulation of sulfa tides. A su ral nerve biopsy was performed in two patients with PD.
In one, no abnormalities were found. In the second, acidic cresyl violet staining revealed a few deposits of brown meta chromatic material perinuclearly in Schwann cells in ad dition to signs of chronic axonal degeneration and regen eration. The ASA activity in this patient was 10 nmol/h per milligram of protein.
C O M M E N T
We describe the signs and symptoms of 13 patients with adult MLD who demonstrated low ASA activity and ac cumulation of sulfatides and of 12 patients with PD. Un til now, only 25 patients with confirmed adult MLD have been described in the literature. In 1991, the clinical signs and symptoms of 23 patients with MLD described in the literature were reviewed by Baumann et nl. 4 One patient from their review was not included in our analysis be cause he was already included as patient 2 in the pres ent study. Recently, two other patients with confirmed MLD have been described. '5, 11 Table 2 summarizes the pre senting symptoms of our patients with adult MLD and the symptoms of the disease in the developed state; it also outlines the clinical symptoms of the patients described in the literature. The mean age at onset in our patients was 23 years (range, 17 to 31 years), comparable with that reported in the literature (mean age at onset, 24 years; range, 16 to 62 years). Most of the patients described were younger than age 40 years at onset, wi th one exception, an elderly patient with an age at onset of 62 years. 14 The m ost com m on p resen tin g sym ptom s de scribed in the literature are mental deterioration and be havioral abnormalities (Table 2 ). In our group, the most common presenting symptoms were ataxia and behav ioral abnormalities, and only two of our patients pre sented with mental deterioration. In the early stages of the disease, the patients were not evaluated with neuro psychological testing, so we cannot rule out that the be havioral abnormalities represent early manifestations of The course of the disease is slowly progi'essive, and the variability in progression is remarkable. Sometimes the patients developed the second and third symptom within 1 year. On the other hand, in one patient, the sec ond symptom did not become evident for 2 0 years. In the developed state of the disease, most of the patients showed mental deterioration, and about half exhibited behavioral abnormalities and ataxia. Sometimes behav ioral abnormalities and dementia15 or polyneuropathy*1 are the only symptoms for many years; this might be why adult MLD is probably underdiagnosed. As in lateinfantile and juvenile MLD, epilepsy tends to be a late feature.2 Only one of the 13 patients became psychotic. On the other hand, in a review of the literature, Iiyde et a 11 suggested that in 53% of patients with adu 11 MLD, psychosis is present and often the initial manifestation. In. most of these patients, however, only ASA activity was determined, while sulfatide accumulation was not dem onstrated, and DNA analysis to exclude PD was not per formed. Of the group of 24 patients with confirmed MLD in the literature, only four were psychotic. 1,1 M'f Appar ently, psychosis is a less common symptom than for merly suggested.
The course of adult MLD is not as rapidly fatal as the. late-infantile and juvenile forms of MLD. Although some of our patients are still alive, we have calculated the mean survival to be at least 1 2 years, which is longer than the survival in late-infantile MLD (3 to 4 years') and juvenile MLD (7 to 9 years);,u
In all the patients who underwent cerebral CT, bila ter a 1 a re as o f hyp o d e ns i Ly w e r e fo u n d i n Lh e wh i t e m a 1 -ter, especially in the frontal lobes. In addition to the ar eas ofhypodensity, cerebral atrophy can be seen as a result of the loss of m yelin.20 In die three patients who under went MRl of the brain, the areas ofhypodensity were more diffuse and pronounced than on CT scans ( Figure 3) . Analysis of the cerebrospinal fluid revealed normal pro tein levels in seven patients and only slightly elevated pro tein levels in three patients, which is in contrast with lateinfantile and juvenile MLD, in which the CSF protein level is usually more markedly elevated (0,44 to 2.25 g/L),*P olyneuropathy is seldom the first clinical symp tom (Table 2) In adult MLD, the process of segmental demyelin ation in the peripheral nerves is less active than in the juvenile and especially the late-infantile forms, The amount of metachromatic deposits does not differ clearly from that of the juvenile form. The moderate to marked slowing of NCVs in adult MLD is in accordance with the pathologic changes in the nerve biopsy specimen indi cating demyelination and reduction of myelin sheath 
Time Alter Onset, y thickness,22 '25 In one patient (patient 6 ) who showed the best-preserved NCVs in our series of patients with adult MLD, accumulation of sulfaticles could be seen on light and electron microscopic examination, but signs of a de myelinating process were minimal, no substantial fiber loss had occurred, and sheath thickness was normal. Com parable findings were reported by Martin et al2fi in a pa tient with adult MLD with moderate slowing of NCVs whose nerve biopsy specimen revealed mild demyelin ation and normal sheath thickness. On the other hand, Fressinaud et al,{1 in their report of a patient with adult MLD with an isolated neuropathy, noted marked slow ing of NCVs and conduction blocks, as well as wide spread demyelinating lesions in the nerve biopsy speci mens. There are apparently marked differences in the severity of the neuropathy within the group of patients with adult MLD. This is also reflected by the electrophysiologic and morphologic features. No correlation exists between the NCV and the am ount of storage material in the peripheral nerve. Treatment of late-infantile MLD with bone mar row transplantation has produced conflicting results,1 but incidental success has been claimed in a few patients whose motor and cognitive development were almost nor mal during several years after bone marrow transplan- tation,27,2H As far as we know, bone marrow transplanta tion has not been reported in cases of adult MLD.
In the 12 patients with PD, no characteristic clini cal syndrome could be detected. An association with mul tiple sclerosis20 and dystonia30 has been suggested, but no causal relationship has been proved. Only one of our patients with PD turned out to have multiple sclerosis. The symptoms and signs of the other 11 patients re vealed no abnormalities as seen in MLD, suggesting that 
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